MONTELUKAST SODIUM

Category
Details Specifications
Therapeutic Category
Leukotriene receptor antagonists (LTRAs), also referred to as leukotriene modifiers. It is also broadly classified as an antiasthmatic and antiallergic agent.
CAT No.
M050000
CAS No.
151767-02-1
Mol. Weight
608.17 g/mol.
Dosage Form
Film-coated tablets, chewable tablets and oral granules.
Appearance
white to off-white powder
Synonyms
MontelukastSodium2-[1-[[(1R)-1-[3-[2-[(7-chloro-2-quinolyl)]vinyl]phenyl]-3-[2-(y-ethyl)phenyl]-propyl]sulfanylmethyl]cyclopropyl]acetic acid sodium salt
Storage
In a closed, light-resistant container at Control room temperature, away from heat, moisture, and direct light

Disclaimer:

The contents on this website is provided solely for informational purposes and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you have any questions about a medical problem, please consult a physician or other authorized health expert. Do not dismiss or postpone getting competent medical advice because of something you read on this website.

Why Shilpa Pharma?

0+

Happy Customers

0+

Projects Successfully Completed

0

Established

0+

PhD Experts Driving R&D Excellence

0+

Team Size

0+

World-Class API Manufacturing Sites

0+

Global Audits Successfully Completed

Comprehensive CDMO Service Offerings

Our MONTELUKAST SODIUM are also Available for

Questions & Answers

FAQ on MONTELUKAST SODIUM

Everything You Need to Know About Shilpa Pharma

Fill the Form

Fill the Form